Metabolic activities and chondrogenic differentiation of human mesenchymal stem cells following recombinant adeno-associated virus-mediated gene transfer and overexpression of fibroblast growth factor 2

Tissue Engineering - Part A

Volumn 17, Issue 15-16, 2011, Pages 1921-1933

  Cucchiarini, Magali ^a   Ekici, Myriam ^a   Schetting, Sarah ^a   Kohn, Dieter ^a   Madry, Henning ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIALS; CARTILAGE; CELL PROLIFERATION; COLLAGEN; DEFECTS; FIBROBLASTS; FLOWCHARTING; GENE THERAPY; GENE TRANSFER; MONOLAYERS; PEPTIDES; PHOSPHATASES; STEM CELLS; TRANSCRIPTION; TRANSCRIPTION FACTORS; VIRUSES;

ADENO-ASSOCIATED VIRUS; AGGREGATE CULTURE; ALKALINE PHOSPHATASE; ARTICULAR CARTILAGE DEFECTS; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; CHONDROGENESIS; CHONDROGENIC; CHONDROGENIC DIFFERENTIATION; DOSE-DEPENDENT; FIBROBLAST GROWTH FACTOR 2; GENETIC MANIPULATIONS; HUMAN FIBROBLAST; HUMAN MESENCHYMAL STEM CELLS; IN-VITRO; IN-VIVO; MATRIX; METABOLIC ACTIVITY; MITOGENIC; OSTEOGENIC; OVER-EXPRESSION; PROTEOGLYCANS; THREE-DIMENSIONAL ENVIRONMENT;

CELL CULTURE;

ADENO-ASSOCIATED VIRUS;

FIBROBLAST GROWTH FACTOR 2;

ADENO ASSOCIATED VIRUS; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSFER; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; METABOLISM; TRANSGENE;

CELL AGGREGATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHONDROGENESIS; DEPENDOVIRUS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 79960793071     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0018     Document Type: Article

References (75)

1. Buckwalter, J.A., and Mankin, H.J. Articular cartilage repair and transplantation. Arthritis Rheum 41, 1331, 1998.
2. O'Driscoll, S.W. The healing and regeneration of articular cartilage. J Bone Joint Surg Am 80, 1795, 1998.
3. Mackay, A.M., Beck, S.C., Murphy, J.M., Barry, F.P., Chichester, C.O., and Pittenger, M.F. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4, 415, 1998.
4. Yoo, J.U., Barther, T.S., Nishimura, K., Solchaga, L., Caplan, A.I., Goldberg, V.M., and Johnstone, B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80, 1745, 1998.
5. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
6. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
7. Evans, C.H., Ghivizzani, S.C., Smith, P., Shuler, F.D., Mi, Z., and Robbins, P.D. Using gene therapy to protect and restore cartilage. Clin Orthop Relat Res 379 Suppl, S214, 2000.
8. Benya, P.D., Padilla, S.R., and Nimni, M.E. The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis. Biochemistry 16, 865, 1977.
9. von der Mark, K., Gauss, V., von der Mark, H., and Muller, P. Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature 267, 531, 1977.
10. Tuan, R.S. Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthritis Rheum 54, 3075, 2006.
11. Steinert, A.F., Ghivizzani, S.C., Rethwilm, A., Tuan, R.S., Evans, C.H., and Nö th, U. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther 9, 213, 2007.
12. Mueller, M.B., and Tuan, R.S. Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells. Arthritis Rheum 58, 1377, 2008.
13. Pelttari, K., Steck, E., and Richter,W. The use ofmesenchymal stem cells for chondrogenesis. Injury 39 Suppl 1, S58, 2008.
14. Cucchiarini, M., and Madry, H. Gene therapy for cartilage defects. J Gene Med 7, 1495, 2005.
15. Wang, W.G., Lou, S.Q., Ju, X.D., Xia, K., and Xia, J.H. In vitro chondrogenesis of human bone marrow-derived mesenchymal progenitor cells in monolayer culture: activation by transfection with TGF-beta2. Tissue Cell 35, 69, 2003.
16. Kawamura, K., Chu, C.R., Sobajima, S., Robbins, P.D., Fu, F.H., Izzo, N.J., and Niyibizi, C. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol 33, 865, 2005.
17. Palmer, G.D., Steinert, A., Pascher, A., Gouze, E., Gouze, J.N., Betz, O., Johnsotne, B., Evans, C.H., and Ghivizzani, S.C. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther 12, 219, 2005.
18. Pagnotto, M.R., Wang, Z., Karpie, J.C., Ferretti, M., Xiao, X., and Chu, C.R. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair. Gene Ther 14, 804, 2007.
19. Steinert, A.F., Palmer, G.D., Pilipil, C., Nö th, U., Evans, C.H., and Ghivizzani, S.C. Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A 15, 1127, 2009.
20. Park, J., Gelse, K., Frank, S., von der Mark, K., Aigner, T., and Schneider, H. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium/periosteum-and fat-derived cells. J Gene Med 8, 112, 2006.
21. Weiss, S., Hennig, T., Bock, R., Steck, E., and Richter, W. Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 223, 84, 2010.
22. Longobardi, L., O'Rear, L., Aakula, S., Johnstone, B., Shimer, K., Chytil, A., Horton, W.A., Moses, H.L., and Spagnoli, A. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 21, 626, 2006.
23. Tsutsumi, S., Shimazu, A., Miyazaki, K., Pan, H., Koike, C., Yoshida, E., Takagishi, K., and Kato, Y. Retention of multilineage differentiation potential of mesenchymal cells during proliferation in response to FGF. Biochem Biophys Res Commun 288, 413, 2001.
24. Ornitz, D.M. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16, 205, 2005.
25. Solchaga, L.A., Penick, K., Goldberg, V.M., Caplan, A.I., and Welter, J.F. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol 203, 398, 2005.
26. Solchaga, L.A., Penick, K., Goldberg, V.M., Caplan, A.I., and Welter, J.F. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 16, 1009, 2010.
27. Tsuchiya, H., Kitoh, H., Sugiura, F., and Ishiguro, N. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 301, 338, 2003.
28. Ikeda, T., Kamekura, S., Mabuchi, A., Seki, S., Takato, T., Nakamura, K., Kawaguchi, H., Ikegawa, S., and Chung, U.I. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50, 3561, 2004.
29. Babister, J.C., Tare, R.S., Green, D.W., Inglis, S., Mann, S., and Oreffo, R.O. Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "beadin-bead" polysaccharide capsules. Biomaterials 29, 58, 2008.
30. Kupcsik, L., Stoddart, M.J., Li, Z., Benneker, L.M., and Alini, M. Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng Part A 16, 1845, 2010.
31. Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Stenderup, K., Rattan, S.I., Jensen, T.G., and Kassem, M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 20, 592, 2002.
32. Hu, B., Ren, J.L., Zhang, J.R., Ma, Q., Liu, Y.P., and Mao, T.Q. Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model. J Tissue Eng Regen Med 4, 105, 2010.
33. Chamberlain, J.R., Schwarze, U., Wang, P.R., Hirata, R.K., Hankeson, K.D., Pace, J.M., Underwood, R.A., Song, K.M., Sussman, M., Byers, P.H., and Russell, D.W. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 1198, 2004.
34. Stender, S., Murphy, M., O'Brien, T., Stengaard, C., Ulrich-Vinther, M., Soballe, K., and Barry, F. Adeno-associated viral vector transduction of human mesenchymal stem cells. Eur Cell Mater 13, 93, 2007.
35. Atchison, R.W., Casto, B.C., and Hammon, W.M. Adenovirus-associated defective virus particles. Science 149, 754, 1965.
36. Watanabe, S., Imagawa, T., Boivin, G.P., Gao, G., Wilson, J.M., and Hirsch, R. Adeno-associated virus mediates longterm gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol Ther 2, 147, 2000.
37. Cucchiarini, M., Madry, H., Ma, C., Thurn, T., Zurakowski, D., Menger, M.D., Kohn, D., Trippel, S.B., and Terwilliger, E.F. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther 12, 229, 2005.
38. Hiraide, A., Yokoo, N., Xin, K.Q., Okuda, K., Mizukami, H., Ozawa, K., and Saito, T. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther 16, 1413, 2005.
39. Ito, H., Koefed, M., Tiyapatanaputi, P., Gromov, K., Goater, J.J., Carmouche, J., Zhang, X., Rubery, P.T., Rabinowitz, J., Samulski, R.J., Nakamura, T., Soballe, K., O'Keefe, R.J., Boyce, B.F., and Schwartz, E.M. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 11, 291, 2005.
40. Kay, J.D., Gouze, E., Oligino, J., Gouze, J.N., Watson, R.S., Levings, P.P., Bush, M.L., Dacanay, A., Nickerson, D.M., Robbins, P.D., Evans, C.H., and Ghivizzani, S.C. Intraarticular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus. J Gene Med 11, 605, 2009.
41. Khoury, M., Courties, G., Fabre, S., Bouffi, C., Seemayer, C.A., Vervoordeldonk, M.J., Tak, P.P., Jorgensen, C., and Apparailly, F. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis. Arthritis Rheum 62, 765, 2010.
42. Mease, P.J., Wei, N., Fudman, E.J., Kivitz, A.J., Schechtman, J., Trapp, R.G., Hobbs, K.F., Greenwald, M., Hou, A., Bookbinder, S.A., Grahma, G.E., Wiesenhutter, C.W., Willis, L., Ruderman, E.M., Forstot, J.Z., Maricic, M.J., Dao, K.H., Pritchard, C.H., Fiske, D.N., Burch, F.X., Prupas, H.M., Anklesaria, P., and Heald A.E. Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 study. J Rheumatol 37, 692, 2010.
43. Kato, Y., and Iwamoto, M. Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem 265, 5903, 1990.
44. Iwasaki, M., Nakahara, H., Nakata, K., Nakase, T., Kimura, T., and Ono, K. Regulation of proliferation and osteochondrogenic differentiation of periosteum-derived cells by transforming growth factor-beta and basic fibroblast growth factor. J Bone Joint Surg Am 77, 543, 1995.
45. Locklin, R.M., Williamson, M.C., Beresford, J.N., Triffitt, J.T., and Owen, M.E. In vitro effects of growth factors and dexamethasone on rat marrow stromal cells. Clin Orthop Relat Res 313, 27, 1995.
46. Locklin, R.M., Oreffo, R.O., and Triffitt, J.T. Effects of TGFbeta and bFGF on the differentiation of human bone marrow stromal fibroblasts. Cell Biol Int 23, 185, 1999.
47. Allen, J.B., Manthey, C.L., Hand, A.R., Ohura, K., Ellingsworth, L., and Wahl, S.M. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 171, 231, 1990.
48. van Beuningen, H.M., van der Kraan, P.M., Arntz, O.J., and van den Berg, W.B. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest 71, 279, 1994.
49. Hunziker, E.B., Driesang, I.M., and Morris, E.A. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin Orthop Relat Res 391 Suppl, S171, 2001.
50. Mi, Z., Ghivizzani, S.C., Lechman, E., Glorioso, J.C., Evans, C.H., and Robbins, P.D. Adverse effects of adenovirusmediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res Ther 5, R132, 2003.
51. Samulski, R.J., Chang, L.S., and Shenk, T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol 61, 3096, 1987.
52. Samulski, R.J., Chang, L.S., and Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J Virol 63, 3822, 1989.
53. Cucchiarini, M., Ren, X.L., Perides, G., and Terwilliger, E.F. Selective gene expression in brain microglia mediated via adeno-associated virus type 2 and type 5 vectors. Gene Ther 10, 657, 2003.
54. Madry, H., Cucchiarini, M., Terwilliger, E.F., and Trippel, S.B. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 14, 393, 2003.
55. Cucchiarini, M., Thurn, T., Weimer, A., Kohn, D., Terwilliger, E.F., and Madry, H. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 56, 158, 2007.
56. Cucchiarini, M., Terwilliger, E.F., Kohn, D., and Madry, H. Remodelling of human osteoarthritic cartilage by FGF-2, alone or combined with Sox9 via rAAV gene transfer. J Cell Mol Med 13, 2476, 2009.
57. Cucchiarini, M., Schetting, S., Terwilliger, E.F., Kohn, D., and Madry, H. rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival, and alpha-SMA expression in human meniscal lesions. Gene Ther 16, 1363, 2009.
58. Steinert, A.F., Proffen, B., Kunz, M., Hendrich, C., Ghivizzani, S.C., Nö th, U., Rethwilm, A., Eulert, J., and Evans, C.H. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 11, R148, 2009.
59. Grä ssel, S., Ahmed, N., Gottl, C., and Grifka, J. Gene and protein expression profile of naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal progenitor cells. Int J MolMed 23, 745, 2009.
60. Wehling, N., Palmer, G.D., Pilapil, C., Liu, F., Wells, J.W., Mü ller, P.E., Evans, C.H., and Porter, R.M. Interleukin-1beta and tumor necrosis factor alpha inhibit chondrogenesis by human mesenchymal stem cells through NF-kappaBdependent pathways. Arthritis Rheum 60, 801, 2009.
61. Trippel, S.B., Wroblewski, J., Makower, A.M., Whelan, M.C., Schoenfeld, D., and Doctrow, S.R. Regulation of growthplate chondrocytes by insulin-like growth-factor I and basic fibroblast growth factor. J Bone Joint Surg Am 75, 177, 1993.
62. Wroblewski, J., and Edwall-Arvidsson, C. Inhibitory effects of basic fibroblast growth factor on chondrocyte differentiation. J Bone Miner Res 10, 735, 1995.
63. Hellingman, C.A., Koevoet, W., Kops, N., Farrell, E., Jahr, H., Liu, W., Baatenburg de Jong, R.J., Frenz, D.A., and von Osch, G.J. Fibroblast growth factor receptors in in vitro and in vivo chondrogenesis: relating tissue engineering using adult mesenchymal stem cells to embryonic development. Tissue Eng Part A 16, 545, 2010.
64. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L., and Karsenty, G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747, 1997.
65. Katayama, R., Wakitani, S., Tsumaki, N., Morita, Y., Matsushita, I., Gejo, R., and Kimura, T. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow. Rheumatology 43, 980, 2004.
66. Wang, W., Li, B., Li, Y., Jiang, Y., Ouyang, H., and Gao, C. In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials 31, 5953, 2010.
67. Kumar, S., Mahendra, G., and Ponnazhagan, S. Determination of osteoprogenitor-specific promoter activity in mouse mesenchymal stem cells by recombinant adeno-associated virus transduction. Biochim Biophys Acta 1731, 95, 2005.
68. Mason, J.M., Breitbart, A.S., Barcia, M., Porti, D., Pergolizzi, R.G., and Grande, D.A. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin Orthop Relat Res 379 Suppl, S171, 2000.
69. Gelse, K., von der Mark, K., Aigner, T., Park, J., and Schneider, H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48, 430, 2003.
70. Madry, H., Kaul, G., Cucchiarini, M., Stein, U., Zurakowski, D., Remberger, K., Menger, M.D., Kohn, D., and Trippel, S.B. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12, 1171, 2005.
71. Kuroda, R., Usas, A., Kubo, S., Corsi, K., Peng, H., Rose, T., Cummins, J., Fu, F.H., and Huard, J. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 54, 433, 2006.
72. Goodrich, L.R., Hidaka, C., Robbins, P.D., Evans, C.H., and Nixon, A.J. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89, 672, 2007.
73. Ivkovic, A., Pascher, A., Hudetz, D., Maticic, D., Jelic, M., Dickinson, S., Loparic, M., Haspl, M., Windhagen, R., and Pecina, M. Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene 17, 779, 2010.
74. Di Cesare, P.E., Frenkel, S.R., Carlson, C.S., Fang, C., and Liu, C. Regional gene therapy for full-thickness articular cartilage lesions using naked DNA with a collagen matrix. J Orthop Res 24, 1118, 2006.
75. Morisset, S., Frisbie, D.D., Robbins, P.D., Nixon, A.J., and McIlwraith, C.W. IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects. Clin Orthop Relat Res 462, 221, 2007.